Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2597-2605

  Clària, Joan ^a,b   Dalli, Jesmond ^a   Yacoubian, Stephanie ^a   Gao, Fei ^a   Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LEUKOTRIENE B4; MONOCYTE CHEMOTACTIC PROTEIN 1; RESOLVIN D1; RESOLVIN D2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOACCUMULATION; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; INFLAMMATION; LIPIDOMICS; METABOLOMICS; MONOCYTE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; DIET, HIGH-FAT; DOCOSAHEXAENOIC ACIDS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MICE; MICE, INBRED C57BL; MICE, OBESE; SUBCUTANEOUS FAT;

EID: 84865408390     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201272     Document Type: Article

References (34)

1. Ferrante, A. W., Jr. 2007. Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. J. Intern. Med. 262: 408-414.
2. Ouchi, N., J. L. Parker, J. J. Lugus, and K. Walsh. 2011. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 11: 85-97.
3. Hotamisligil, G. S. 2006. Inflammation and metabolic disorders. Nature 444: 860-867.
4. Lumeng, C. N., and A. R. Saltiel. 2011. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121: 2111-2117.
5. Zeyda, M., and T. M. Stulnig. 2007. Adipose tissue macrophages. Immunol. Lett. 112: 61-67.
6. Weisberg, S. P., D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante, Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112: 1796-1808.
7. Serhan, C. N., S. D. Brain, C. D. Buckley, D. W. Gilroy, C. Haslett, L. A. J. O'Neill, M. Perretti, A. G. Rossi, and J. L. Wallace. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21: 325-332.
8. Serhan, C. N. 2007. Resolution phase of inflammation: novel endogenous antiinflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25: 101-137.
9. González-Périz, A., R. Horrillo, N. Ferré, K. Gronert, B. Dong, E. Morán-Salvador, E. Titos, M. Martínez- Clemente, M. López-Parra, V. Arroyo, and J. Clària. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23: 1946-1957.
10. Todoric, J., M. Löffler, J. Huber, M. Bilban, M. Reimers, A. Kadl, M. Zeyda, W. Waldhäusl, and T. M. Stulnig. 2006. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia 49: 2109-2119.
11. Ramel, A., A. Martinéz, M. Kiely, G. Morais, N. M. Bandarra, and I. Thorsdottir. 2008. Beneficial effects of long-chain n-3 fatty acids included in an energyrestricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 51: 1261-1268.
12. Petro, A. E., J. Cotter, D. A. Cooper, J. C. Peters, S. J. Surwit, and R. S. Surwit. 2004. Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse. Metabolism 53: 454-457.
13. Yang, R., N. Chiang, S. F. Oh, and C. N. Serhan. 2011. Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr. Protoc. Immunol. 95:14.26.11-14.26.26.
14. Kasuga, K., R. Yang, T. F. Porter, N. Agrawal, N. A. Petasis, D. Irimia, M. Toner, and C. N. Serhan. 2008. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181: 8677-8687.
15. Serhan, C. N., R. Yang, K. Martinod, K. Kasuga, P. S. Pillai, T. F. Porter, S. F. Oh, and M. Spite. 2009. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206: 15-23.
16. Krishnamoorthy, S., A. Recchiuti, N. Chiang, S. Yacoubian, C.-H. Lee, R. Yang, N. A. Petasis, and C. N. Serhan. 2010. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc. Natl. Acad. Sci. USA 107: 1660-1665.
17. Shimizu, T. 2009. Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 49: 123-150.
18. Quinn, C. E., P. K. Hamilton, C. J. Lockhart, and G. E. McVeigh. 2008. Thiazolidinediones: effects on insulin resistance and the cardiovascular system. Br. J. Pharmacol. 153: 636-645.
19. Bazzoni, F., N. Tamassia, M. Rossato, and M. A. Cassatella. 2010. Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur. J. Immunol. 40: 2360-2368.
20. Sun, Y.-P., S. F. Oh, J. Uddin, R. Yang, K. Gotlinger, E. Campbell, S. P. Colgan, N. A. Petasis, and C. N. Serhan. 2007. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282: 9323-9334.
21. Clish, C. B., Y. P. Sun, and C. N. Serhan. 2001. Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase. Biochem. Biophys. Res. Commun. 288: 868-874.
22. Tomlinson, J. W., and P. M. Stewart. 2002. The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue. Horm. Metab. Res. 34: 746-751.
23. Brozic, P., B. Golob, N. Gomboc, T. L. Rizner, and S. Gobec. 2006. Cinnamic acids as new inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3). Mol. Cell. Endocrinol. 248: 233-235.
24. Tai, H. H., C. M. Ensor, M. Tong, H. Zhou, and F. Yan. 2002. Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat. 68-69: 483-493.
25. Eltzschig, H. K., and P. Carmeliet. 2011. Hypoxia and inflammation. N. Engl. J. Med. 364: 656-665.
26. Ye, J. 2009. Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int. J. Obes. (Lond.) 33: 54-66.
27. Serhan, C. N. 2004. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem. Cell Biol. 122: 305-321.
28. White, P. J., M. Arita, R. Taguchi, J. X. Kang, and A. Marette. 2010. Transgenic restoration of long-chain n-3 fatty acids in insulin target tissues improves resolution capacity and alleviates obesity-linked inflammation and insulin resistance in high-fat-fed mice. Diabetes 59: 3066-3073.
29. Eckle, T., K. Hartmann, S. Bonney, S. Reithel, M. Mittelbronn, L. A. Walker, B. D. Lowes, J. Han, C. H. Borchers, P. M. Buttrick, et al. 2012. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat. Med. 18: 774-782.
30. Perretti, M., and F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9: 62-70.
31. Nakahata, Y., M. Akashi, D. Trcka, A. Yasuda, and T. Takumi. 2006. The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks. BMC Mol. Biol. 7: 5.
32. Csermely P., T. Korcsmáros, and K. Sulyok, eds. 2007. Stress Responses in Biology and Medicine: Stress of Life in Molecules, Cells, Organisms, and Psychosocial Communities. Blackwell Publishing, Boston.
33. Titos, E., B. Rius, A. González-Périz, C. López-Vicario, E. Morán-Salvador, M. Martínez-Clemente, V. Arroyo, and J. Clària. 2011. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward anM2-like phenotype. J. Immunol. 187: 5408-5418.
34. Hellmann, J., Y. Tang, M. Kosuri, A. Bhatnagar, and M. Spite. 2011. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 25: 2399-2407.